Literature DB >> 19190464

Treatment of experimental aneurysms with an embolic-containing device and liquid embolic agent: feasibility and angiographic and histological results.

Alejandro Berenstein1, Joon K Song, Tomoyuki Tsumoto, Katsunari Namba, Yasunari Niimi.   

Abstract

OBJECTIVE: To assess the feasibility and analyze angiographic and histological results of experimental aneurysms treated with an embolic-containing device (ECD) and to test a liquid embolic agent (LEA), N-butyl cyanoacrylate.
METHODS: Four experimental large bifurcation aneurysms and 1 large sidewall aneurysm were created in 5 dogs. These venous pouch aneurysms were occluded endosaccularly with an ECD and N-butyl cyanoacrylate. Angiographic and/or histopathological data were analyzed at 1 day (bifurcation), 1 week (bifurcation), 4 months (sidewall), 6 months (bifurcation), and 12 months (bifurcation).
RESULTS: Aneurysm dimensions were 16 to 18 mm in length, 6 to 8 mm in width, and a neck measuring 6 to 8 mm. Immediately after the procedure, 2 of 4 bifurcation aneurysms were 100% occluded. In one case, glue had spilled into the parent artery. One occluded aneurysm recanalized at 6 months. One occluded aneurysm remained closed at 12 months. Histopathological analysis of the 6- and 12-month specimens showed adherence of glue to the aneurysm wall, no appreciable inflammatory response to the ECD, and aneurysm wall fibrosis with adventitial chronic inflammation. The aneurysm necks were covered by neointima with the presence of endothelialization.
CONCLUSION: Within the limitations of this experimental study, treatment of large, wide-necked aneurysms with the ECD and LEA may be feasible. Suboptimal technique and ECD geometry can cause leakage of LEA into the parent vessel or incomplete apposition of the ECD/glue to the aneurysm wall. However, the ECD and glue injection technique did achieve complete occlusion in 1 aneurysm that persisted 1 year later. The histopathological findings in this instance are moderately encouraging. Further investigations of an ECD with N-butyl cyanoacrylate or another LEA are warranted.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19190464     DOI: 10.1227/01.NEU.0000335790.91413.64

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  4 in total

1.  Swine hybrid aneurysm model for endovascular surgery training.

Authors:  K Namba; K Mashio; Y Kawamura; A Higaki; S Nemoto
Journal:  Interv Neuroradiol       Date:  2013-05-21       Impact factor: 1.610

2.  Guidelines for the use of NBCA in vascular embolization devised by the Committee of Practice Guidelines of the Japanese Society of Interventional Radiology (CGJSIR), 2012 edition.

Authors:  Yoshito Takeuchi; Hiroyuki Morishita; Yozo Sato; Shingo Hamaguchi; Noriaki Sakamoto; Hiroyuki Tokue; Takafumi Yonemitsu; Kenji Murakami; Hiroyasu Fujiwara; Keitaro Sofue; Toshi Abe; Hideyuki Higashihara; Yasuo Nakajima; Morio Sato
Journal:  Jpn J Radiol       Date:  2014-06-03       Impact factor: 2.374

Review 3.  The development and the use of experimental animal models to study the underlying mechanisms of CA formation.

Authors:  Tomohiro Aoki; Masaki Nishimura
Journal:  J Biomed Biotechnol       Date:  2010-12-28

4.  Lumen-oriented versus wall-oriented treatment strategies for intracranial aneurysms - A systematic review of suggested therapeutic concepts.

Authors:  Basil E Grüter; Fabio von Faber-Castell; Serge Marbacher
Journal:  J Cereb Blood Flow Metab       Date:  2021-11-19       Impact factor: 6.960

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.